DOCUDOCUSIGN, INC.

Nasdaq DocuSign.com


$ 59.83 $ 1.04 (1.77 %)    

Friday, 03-May-2024 15:59:53 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 59.8
$ 59.54
$ 0.00 x 0
$ 0.00 x 0
$ 58.84 - $ 59.92
$ 38.11 - $ 64.76
1,294,556
na
12.5B
$ 1.38
$ 168.90
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-21-2024 01-31-2024 10-K
2 12-08-2023 10-31-2023 10-Q
3 09-07-2023 07-31-2023 10-Q
4 06-08-2023 04-30-2023 10-Q
5 03-27-2023 01-31-2023 10-K
6 12-08-2022 10-31-2022 10-Q
7 09-08-2022 07-31-2022 10-Q
8 06-09-2022 04-30-2022 10-Q
9 03-25-2022 01-31-2022 10-K
10 12-06-2021 10-31-2021 10-Q
11 09-03-2021 07-31-2021 10-Q
12 06-04-2021 04-30-2021 10-Q
13 03-31-2021 01-31-2021 10-K
14 12-04-2020 10-31-2020 10-Q
15 09-04-2020 07-31-2020 10-Q
16 06-05-2020 04-30-2020 10-Q
17 03-27-2020 01-31-2020 10-K
18 12-06-2019 10-31-2019 10-Q
19 09-06-2019 07-31-2019 10-Q
20 06-07-2019 04-30-2019 10-Q
21 03-26-2019 01-31-2019 10-K
22 12-07-2018 10-31-2018 10-Q
23 09-06-2018 07-31-2018 10-Q
24 06-08-2018 04-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rbc-capital-reiterates-sector-perform-on-docusign-maintains-59-price-target

RBC Capital analyst Rishi Jaluria reiterates DocuSign (NASDAQ:DOCU) with a Sector Perform and maintains $59 price target.

 jmp-securities-reiterates-market-outperform-on-docusign-maintains-84-price-target

JMP Securities analyst Patrick Walravens reiterates DocuSign (NASDAQ:DOCU) with a Market Outperform and maintains $84 price ...

 ubs-upgrades-docusign-to-neutral-raises-price-target-to-62

UBS analyst Karl Keirstead upgrades DocuSign (NASDAQ:DOCU) from Sell to Neutral and raises the price target from $48 to $62.

 needham-reiterates-hold-on-docusign

Needham analyst Scott Berg reiterates DocuSign (NASDAQ:DOCU) with a Hold.

 dell-designer-brands-and-2-other-stocks-insiders-are-selling

The Nasdaq 100 closed lower by around 150 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.

 docusign-reports-opening-up-a-new-saas-category---intelligent-agreement-management

The company unveiled Docusign IAM, an Intelligent Agreement Management platform and suite of applications to lead that category. 

 citigroup-maintains-buy-on-docusign-raises-price-target-to-93

Citigroup analyst Tyler Radke maintains DocuSign (NASDAQ:DOCU) with a Buy and raises the price target from $90 to $93.

 baird-maintains-neutral-on-docusign-raises-price-target-to-65

Baird analyst William Power maintains DocuSign (NASDAQ:DOCU) with a Neutral and raises the price target from $50 to $65.

 stocks-fall-as-chipmakers-retreat-from-highs-bitcoin-pulls-back-after-70000-gold-rises-to-2200-whats-driving-markets-friday

The stock market is navigating a mixed closing session this week, with the S&P 500 and Nasdaq 100 struggling to stave off a...

 jmp-securities-reiterates-market-outperform-on-docusign-maintains-84-price-target

JMP Securities analyst Patrick Walravens reiterates DocuSign (NASDAQ:DOCU) with a Market Outperform and maintains $84 price ...

 rbc-capital-maintains-sector-perform-on-docusign-raises-price-target-to-59

RBC Capital analyst Rishi Jaluria maintains DocuSign (NASDAQ:DOCU) with a Sector Perform and raises the price target from $5...

 wedbush-maintains-neutral-on-docusign-raises-price-target-to-65

Wedbush analyst Daniel Ives maintains DocuSign (NASDAQ:DOCU) with a Neutral and raises the price target from $56 to $65.

 oppenheimer-maintains-perform-on-docusignto-perform

Oppenheimer analyst George Iwanyc maintains DocuSign (NASDAQ:DOCU) from Perform to Perform.

 these-analysts-increase-their-forecasts-on-docusign-after-upbeat-results

DocuSign Inc (NASDAQ: DOCU) reported better-than-expected fourth-quarter financial results on Thursday.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION